Antigen-induced regulatory T cells

被引:81
作者
Vigouroux, S
Yvon, E
Biagi, E
Brenner, MK
机构
[1] Baylor Coll Med, Texas Childrens Hosp, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
[2] Baylor Coll Med, Texas Childrens Hosp, Dept Pediat, Houston, TX 77030 USA
[3] Baylor Coll Med, Texas Childrens Hosp, Dept Med, Houston, TX 77030 USA
[4] Methodist Hosp, Houston, TX 77030 USA
关键词
D O I
10.1182/blood-2004-01-0182
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Regulatory T cells participate in immunologic homeostasis by active suppression of inappropriate immune responses. Regulatory T lymphocytes expressing CD4 and CD25 antigens and naturally present in the peripheral blood were the first to be phenotypically characterized. However, their small number and antigen nonspecific suppression has prompted efforts to identify and dissect antigen-specific regulatory T cells. In this review we discuss how antigen-specific regulatory T cells can be identified, the cellular and molecular mechanisms underlying their induction and activity, and the challenges facing their potential clinical application. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:26 / 33
页数:8
相关论文
共 90 条
  • [1] Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745
  • [2] Intratracheal delivery of a single major histocompatibility complex class I peptide induced prolonged survival of fully allogeneic cardiac grafts and generated regulatory cells
    Akiyama, Y
    Shirasugi, N
    Aramaki, O
    Matsumoto, K
    Shimazu, M
    Kitajima, M
    Ikeda, Y
    Niimi, M
    [J]. HUMAN IMMUNOLOGY, 2002, 63 (10) : 888 - 892
  • [3] B7/CTLA4 pathway is essential for generating regulatory cells after intratracheal delivery of alloantigen in mice
    Akiyama, Y
    Shirasugi, N
    Uchida, N
    Matsumoto, K
    Kitajima, M
    Bashuda, H
    Yagita, H
    Okumura, K
    Aramaki, O
    Niimi, M
    [J]. TRANSPLANTATION, 2002, 74 (05) : 732 - 738
  • [4] High dose of antithrombin III induces indefinite survival of fully allogeneic cardiac grafts and generates regulatory cells
    Aramaki, O
    Takayama, T
    Yokoyama, T
    Takano, S
    Akiyama, Y
    Shibutani, S
    Matsumoto, K
    Shimazu, M
    Kitajima, M
    Ikeda, Y
    Shirasugi, N
    Niimi, M
    [J]. TRANSPLANTATION, 2003, 75 (02) : 217 - 220
  • [5] CD4+CD25high regulatory cells in human peripheral blood
    Baecher-Allan, C
    Brown, JA
    Freeman, GJ
    Hafler, DA
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (03) : 1245 - 1253
  • [6] An overview of the Notch signalling pathway
    Baron, M
    [J]. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2003, 14 (02) : 113 - 119
  • [7] In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines
    Barrat, FJ
    Cua, DJ
    Boonstra, A
    Richards, DF
    Crain, C
    Savelkoul, HF
    de Waal-Malefyt, R
    Coffman, RL
    Hawrylowicz, CM
    O'Garra, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) : 603 - 616
  • [8] TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes
    Belghith, M
    Bluestone, JA
    Barriot, S
    Mégret, J
    Bach, JF
    Chatenoud, L
    [J]. NATURE MEDICINE, 2003, 9 (09) : 1202 - 1208
  • [9] ORAL-ADMINISTRATION OF HUMAN INSULIN TO NOD MICE GENERATES CD4(+) T-CELLS THAT SUPPRESS ADOPTIVE TRANSFER OF DIABETES
    BERGEROT, I
    FABIEN, N
    MAGUER, V
    THIVOLET, C
    [J]. JOURNAL OF AUTOIMMUNITY, 1994, 7 (05) : 655 - 663
  • [10] Epicutaneous immunization with autoantigenic peptides induces T suppressor cells that prevent experimental allergic encephalomyelitis
    Bynoe, MS
    Evans, JT
    Viret, C
    Janeway, CA
    [J]. IMMUNITY, 2003, 19 (03) : 317 - 328